Turin Chemicals Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 21-12-2024
- Paid Up Capital ₹ 0.10 M
as on 21-12-2024
- Company Age 25 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 17.02%
(FY 2022)
- Profit 142.30%
(FY 2022)
- Ebitda 11.88%
(FY 2022)
- Net Worth 1.95%
(FY 2022)
- Total Assets -5.25%
(FY 2022)
About Turin Chemicals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Azra Sultana, Saleem Tuba, and Bushra Tayyaba serve as directors at the Company.
- CIN/LLPIN
U15499TG1999PTC031079
- Company No.
031079
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Feb 1999
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Turin Chemicals Private Limited offer?
Turin Chemicals Private Limited offers a wide range of products and services, including Animal Feed, Pellet Feed, Feed Additives, Cattle Feed Additives.
Who are the key members and board of directors at Turin Chemicals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Azra Sultana  | Managing Director | 10-Feb-1999 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Saleem Tuba | Director | 13-Oct-2017 | Current |
| Bushra Tayyaba | Director | 21-Oct-2019 | Current |
Financial Performance of Turin Chemicals.
Turin Chemicals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 17.02% increase. The company also saw a substantial improvement in profitability, with a 142.3% increase in profit. The company's net worth moved up by a moderate rise of 1.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Turin Chemicals?
Unlock access to Turin Chemicals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Turin Chemicals?
Unlock and access historical data on people associated with Turin Chemicals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Turin Chemicals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Turin Chemicals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
